22 Nw, LP Anebulo Pharmaceuticals, Inc. Transaction History

22 Nw, LP

$119 Million
Q4 2024

A detailed history of 22 Nw, LP transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, 22 Nw, LP holds 15,467,300 shares of ANEB stock, worth $19.5 Million. This represents 21.77% of its overall portfolio holdings.

Number of Shares

15,467,300

Previous 5,366,290 188.23%

Holding current value

$19.5 Million

Previous $10.4 Million 150.92%

% of portfolio

21.77%

Previous 11.7%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.99 - $1.98 $10 Million - $20 Million	10,101,010 Added 188.23%	15,467,300 $26 Million
Q4 2023 Feb 14, 2024	BUY	$1.71 - $3.17 $513,000 - $951,000	300,000 Added 5.92%	5,366,290 $13 Million
Q3 2022 Nov 14, 2022	BUY	$2.8 - $5.49 $4.77 Million - $9.35 Million	1,703,577 Added 50.66%	5,066,290 $14.2 Million
Q4 2021 Feb 14, 2022	BUY	$5.84 - $7.3 $111,824 - $139,780	19,148 Added 0.57%	3,362,713 $20.7 Million
Q2 2021 Aug 16, 2021	BUY	$6.58 - $8.95 $22 Million - $29.9 Million	3,343,565 New	3,343,565 $22.8 Million

Others Institutions Holding ANEB

# of Institutions

Shares Held

22.6M

Call Options Held

Put Options Held

View Full List

About Anebulo Pharmaceuticals, Inc.

Ticker ANEB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,633,200
Market Cap $32.3M
Description
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...

More about ANEB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 22 Nw, LP, based on Form 13F filings with the SEC.

News

Stay updated on 22 Nw, LP with notifications on news.

Account